The Andersen Model of Total Patient Delay: a systematic review of its application in cancer diagnosis.
Walter F, Webster A, Scott S, Emery J. · 2012
Read The Andersen Model of Total Patient Delay: a systematic review of its application in cancer diagnosis. by Walter F, Webster A, Scott S, Emery J. (2012) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3336942.txt.
Introduction
Walter, Webster, Scott, and Emery reviewed studies that applied a classic model of delay in cancer diagnosis, publishing in 2012. The path from noticing a symptom to starting treatment has several stages, and delays at any stage can worsen outcomes. The Andersen model names five stages, from first judging a symptom to receiving treatment, yet most studies of diagnostic delay use no model at all.
Only ten papers, covering eight studies, met the reviewers' bar of actually applying the model. Evidence strongly supported two stages, the time spent appraising symptoms and delays within treatment, though the treatment stage needs widening. Scheduling delay had some support, while one proposed stage, illness delay, proved hard to separate from appraisal. The authors propose refinements to the model and plead for more consistent study design and reporting.
Catalog record
| CREATOR | Walter F, Webster A, Scott S, Emery J. |
|---|---|
| YEAR | 2012 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
The Andersen Model of Total Patient Delay: a systematic review of its application in cancer diagnosis By Fiona Walter, Andrew Webster, Suzanne Scott, Jon Emery Published in: Journal of Health Services Research & Policy DOI: 10.1258/jhsrp.2011.010113 ABSTRACT Abstract Objective Patient pathways to presentation to health care professionals and initial management in primary care are key determinants of outcomes in cancer. Reducing diagnostic delays may result in improved prognosis and increase the proportion of early stage cancers identified. Investigating diagnostic delay could be facilitated by use of a robust theoretical framework. We systematically reviewed the literature reporting the application of Andersen's Model of Total Patient Delay (delay stages: appraisal, illness, behavioural, scheduling, treatment) in studies which assess cancer diagnosis. Methods We searched four electronic databases and conducted a narrative synthesis. Inclusion criteria were studies which: reported primary research, focused on cancer diagnosis and explicitly applied one or more stages of the Andersen Model in the collection or analysis of data. Results The vast majority of studies of diagnostic delay in cancer have not applied a theoretical model to inform data collection or reporting. Ten papers (reporting eight studies) met our inclusion criteria: three studied several cancers. The studies were heterogeneous in their methods and quality. The review confirmed that there are clearly identifiable stages between the recognition of a symptom, first presentation to a health care professional, subsequent diagnosis and initiation of treatment. There was strong evidence to support the existence and importance of appraisal and treatment delay as defined in the Andersen Model, although treatment delay requires expansion. There was some evidence to support scheduling delay which may be contributed to by both patient and the health service. Illness delay was often difficult to distinguish from appraisal delay. It was less clear whether behavioural delay exists as a separate significant stage. Conclusions Greater consistency is required in the conduct and reporting of studies of diagnostic delay in cancer. We propose refinements to the Andersen Model which could be used to increase its validity and improve the consistency of reporting in future studies. INTRODUCTION The UK has poorer cancer survival rates compared with other European countries with similar health care systems and expenditure.1 There is evidence that patient pathways to presentation, and initial management in the primary care setting, are key determinants of cancer patient outcomes.2 In the UK, patient delays in consulting health care professionals (HCPs) for symptoms and primary care delays in diagnosis contribute to a greater proportion of the time from the onset of symptoms to a definitive diagnosis than delays in referral or delays in starting cancer treatment.3 Reducing diagnostic delays may increase the proportion of early stage cancers identified, improve prognosis and reduce psychological distress.4 Current UK government policy (National Awareness and Early Diagnosis Initiative) supports raising public awareness of cancer symptoms, encouraging people to seek help earlier for these symptoms, and increasing the evidence base around diagnostic delay with the aim of improving clinical outcomes. Most cancers are symptomatic (e.g. prostate 80%; breast and colorectal 75%),5 and most patients present these symptoms to their HCPs. However, cancer symptoms are the same as the symptoms of many other, more common, non-malignant conditions, and the vast majority of the time these symptoms do not herald serious diseases. To inform approaches to reduce diagnostic delay it is important to understand patient pathways to cancer diagnosis, including the timing and reasons behind the decision to seek help. A wide range of factors that directly or indirectly influence the time taken to seek help have been identified including: patient factors (e.g. age, gender), provider or system factors (e.g. access, patient-doctor communication), psychological factors (e.g. anxiety, fear), social factors (e.g. competing priorities as worker/carer) and behavioural factors (e.g. self-medication, watchful waiting).6 While there is a substantial literature on delays in cancer diagnosis, it suffers from a lack of consensus not only on the definitions and terms used, but also time intervals measured along the diagnostic pathway. This may be because most research into symptom appraisal and patient pathways has lacked a theoretical framework; these provide a systematic approach to improve understanding by building on existing knowledge and allowing hypothesis generation. Applying a theoretical framework to study delay in cancer diagnosis could underpin the development of future interventions to reduce patient time to presentation, diagnosis and cancer treatment.7 Although few frameworks are used in cancer diagnostics research, the most widely cited theoretical model was first proposed by Safer et al.8 and subsequently developed by Andersen et al.9 Safer et al. proposed a three-stage model to account for the total time from first noticing a symptom to seeking treatment. ‘Appraisal delay’ described the time a person takes to evaluate a symptom as a sign of illness, ‘illness delay’ the time the person takes from the first sign of illness until deciding to seek professional medical care, and ‘utilization delay’ the time from the decision to seek care until the person consults a HCP. Andersen et al. presented a General Model of Total Patient Delay (‘the Andersen Model’) which could be applied to a variety of disorders. They conceptualized delay intervals occurring between phases of decision-making (the components of delay), and extended the model by replacing Safer et al.'s ‘utilization delay’ with ‘behavioural delay’ to describe the time between a person deciding an illness requires medical care and deciding to act on this decision; ‘scheduling delay’ the time between deciding to act on the decision to seek help and actually attending an appointment; and ‘treatment delay’ the time between the first appointment with a HCP and the onset of treatment (see Figure 1). [Figure: The General Model of Total Patient Delay as proposed by Andersen et al. (1995). Reproduced with permission from the British Journal of Social Psychology © The British Psychological Society9] It is important to recognize subtle differences between Safer's original model and the Andersen Model: while Safer et al. used ‘stage’ to describe the delay time, Andersen et al. used ‘stage’ to describe not only the delay time but also the components of delay or phases of decision-making. Throughout this paper we shall apply the following terms for the sake of consistency: (a) ‘stage’ to describe the delay time, and (b) ‘components of delay’ to describe the decisional and appraisal processes that mark the beginning and end points of stages. Since its publication, the Andersen Model has been used to investigate delay in the diagnosis of many conditions such as myocardial infarction10 as well as cancer. This systematic review had two aims: first, to examine the application of the Andersen Model in studies which assess cancer diagnosis, and second, to assess the utility of the Andersen Model in conceptualizing and measuring the stages leading to cancer diagnosis. METHODS We performed systematic searches of the literature, followed by critical appraisal of included studies and a narrative synthesis. Systematic search Data sources and search strategy Our guiding definition to inform the initial search strategy was ‘published papers (quantitative and qualitative) which applied the Andersen Model during the collection and/or analysis of data in studies assessing cancer diagnosis’. We used a scoping exercise involving seven relevant papers to refine our search terms, and then conducted a systematic search of four electronic databases: PubMed, Web